PENTETATE ZINC TRISODIUM | N021751 | HAMELN PHARMA PLUS GMBH
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Attachment I - From: "Young, Johnny"<Johnny.Young@fda.hhs.gov> "Suitability P... FDA-2010-P-0630 Heyltex Corporation, on behalf of HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG, filed Suitability Petition 2009-P-0258 requesting FDA approval regarding Pentetate Zinc Trisodium Injection, a chelation agent used in nuclear medicine for treating certain types of heavy metal poisoning and intern | Suitability | 2010-12-20 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.